BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9161879)

  • 21. Distinct T cell receptor signaling requirements for perforin- or FasL-mediated cytotoxicity.
    Esser MT; Krishnamurthy B; Braciale VL
    J Exp Med; 1996 Apr; 183(4):1697-706. PubMed ID: 8666927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fas-independent cytotoxicity mediated by human CD4+ CTL directed against herpes simplex virus-infected cells.
    Yasukawa M; Ohminami H; Yakushijin Y; Arai J; Hasegawa A; Ishida Y; Fujita S
    J Immunol; 1999 May; 162(10):6100-6. PubMed ID: 10229852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The fungal metabolite gliotoxin: immunosuppressive activity on CTL-mediated cytotoxicity.
    Yamada A; Kataoka T; Nagai K
    Immunol Lett; 2000 Jan; 71(1):27-32. PubMed ID: 10709782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of lysis by cytotoxic T lymphocyte clones. Lytic activity and gene expression in cloned antigen-specific CD4+ and CD8+ T lymphocytes.
    Lancki DW; Hsieh CS; Fitch FW
    J Immunol; 1991 May; 146(9):3242-9. PubMed ID: 1673149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
    Seki N; Brooks AD; Carter CR; Back TC; Parsoneault EM; Smyth MJ; Wiltrout RH; Sayers TJ
    J Immunol; 2002 Apr; 168(7):3484-92. PubMed ID: 11907109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Essential roles of perforin in antigen-specific cytotoxicity mediated by human CD4+ T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells.
    Yanai F; Ishii E; Kojima K; Hasegawa A; Azuma T; Hirose S; Suga N; Mitsudome A; Zaitsu M; Ishida Y; Shirakata Y; Sayama K; Hashimoto K; Yasukawa M
    J Immunol; 2003 Feb; 170(4):2205-13. PubMed ID: 12574394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of the lytic activity of perforin by lipoproteins.
    Tschopp J; Masson D; Schäfer S
    J Immunol; 1986 Sep; 137(6):1950-3. PubMed ID: 2427587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Omeprazole and bafilomycin, two proton pump inhibitors: differentiation of their effects on gastric, kidney and bone H(+)-translocating ATPases.
    Mattsson JP; Väänänen K; Wallmark B; Lorentzon P
    Biochim Biophys Acta; 1991 Jun; 1065(2):261-8. PubMed ID: 1647821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemistry and structure activity relationships of bafilomycin A1, a potent and selective inhibitor of the vacuolar H+-ATPase.
    Gagliardi S; Rees M; Farina C
    Curr Med Chem; 1999 Dec; 6(12):1197-212. PubMed ID: 10519916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative roles of Na+/H+ exchange and vacuolar-type H+ ATPases in regulating cytoplasmic pH and function in murine peritoneal macrophages.
    Swallow CJ; Grinstein S; Sudsbury RA; Rotstein OD
    J Cell Physiol; 1993 Dec; 157(3):453-60. PubMed ID: 8253856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of vacuolar H(+)-ATPase in the control of intragranular pH and exocytosis in eosinophils.
    Kurashima K; Numata M; Yachie A; Sai Y; Ishizaka N; Fujimura M; Matsuda T; Ohkuma S
    Lab Invest; 1996 Nov; 75(5):689-98. PubMed ID: 8941214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice.
    Johnson BJ; Costelloe EO; Fitzpatrick DR; Haanen JB; Schumacher TN; Brown LE; Kelso A
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2657-62. PubMed ID: 12601154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two types of anti-TL (thymus leukemia) CTL clones with distinct target specificities: differences in cytotoxic mechanisms and accessory molecule requirements.
    Tsujimura K; Takahashi T; Iwase S; Matsudaira Y; Kaneko Y; Yagita H; Obata Y
    J Immunol; 1998 Jun; 160(11):5253-61. PubMed ID: 9605121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies of the mechanism of cytolysis by tumour-infiltrating lymphocytes.
    Hishii M; Kurnick JT; Ramirez-Montagut T; Pandolfi F
    Clin Exp Immunol; 1999 Jun; 116(3):388-94. PubMed ID: 10361224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of CPP32-like proteases prevents granzyme B- and Fas-, but not granzyme A-based cytotoxicity exerted by CTL clones.
    Anel A; Gamen S; Alava MA; Schmitt-Verhulst AM; Piñeiro A; Naval J
    J Immunol; 1997 Mar; 158(5):1999-2006. PubMed ID: 9036942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suicide induced by cytolytic activity controls the differentiation of memory CD8(+) T lymphocytes.
    Opferman JT; Ober BT; Narayanan R; Ashton-Rickardt PG
    Int Immunol; 2001 Apr; 13(4):411-9. PubMed ID: 11282980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vacuolar-type H+-ATPase regulates cytoplasmic pH in Toxoplasma gondii tachyzoites.
    Moreno SN; Zhong L; Lu HG; Souza WD; Benchimol M
    Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):853-60. PubMed ID: 9480901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A calcium- and perforin-independent pathway of killing mediated by murine cytolytic lymphocytes.
    Young JD; Clark WR; Liu CC; Cohn ZA
    J Exp Med; 1987 Dec; 166(6):1894-9. PubMed ID: 3500267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection.
    Andersson J; Behbahani H; Lieberman J; Connick E; Landay A; Patterson B; Sönnerborg A; Loré K; Uccini S; Fehniger TE
    AIDS; 1999 Jul; 13(11):1295-303. PubMed ID: 10449281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perforin hyperreleasability and depletion in cytotoxic T cells from patients with exacerbated atopic dermatitis and asymptomatic rhinoconjunctivitis allergica.
    Ambach A; Bonnekoh B; Gollnick H
    J Allergy Clin Immunol; 2001 May; 107(5):878-86. PubMed ID: 11344356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.